An oral aromatase inhibitor (AI), is an endocrine (hormonal) therapy for the treatment of hormone-sensitive breast cancer in postmenopausal women.

Anastrozole

An oral non-steroidal anti-androgen for the treatment of prostate cancer.

Bicalutamide

An estrogen receptor antagonist for advanced breast cancer, administered as a once monthly injection.

Fulvestrant

An epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitor, that acts to block signals for cancer cell growth and survival in non-small cell lung cancer.

Gefitinib

An oral anti-oestrogen for the treatment of breast cancer.

Tamoxifen Citrate

An injectable luteinising hormone-releasing hormone analogue (LHRHa) administered as ZOLADEX SafeSystem. It stops the production of testosterone and oestrogen in the testes or ovaries and is used to treat hormone-sensitive cancers of the prostate and breast (in pre-/perimenopausal women) and some benign gynaecological disorders (endometriosis, uterine fibroids and endometrial thinning). In addition, Zoladex is used in assisted reproduction.

Goserelin Acetate